JOHNSON & JOHNSON is 68.5x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($574.10 B vs $8.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CORT | JNJ |
|---|---|---|
| Market cap | $8.39 B | $574.10 B |
| US-listed rank | #1039 | #20 |
| Revenue (latest FY) | $761.41M | $94.19B |
| Net income (latest FY) | $99.65M | $26.80B |
| Net margin | 13.1% | 28.5% |
| P/E (trailing FY) | 84.2 | 21.4 |
| SEC filings | 1,955 | 984 |
JOHNSON & JOHNSON is 68.5x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($574.10 B vs $8.39 B).
In their latest fiscal years, CORCEPT THERAPEUTICS INC reported $761.41M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: CORCEPT THERAPEUTICS INC and JOHNSON & JOHNSON, or browse the full rankings.